Comparison of azelnidipine and trichlormethiazide in Japanese type 2 diabetic patients with hypertension: the COAT randomized controlled trial.

Trial Profile

Comparison of azelnidipine and trichlormethiazide in Japanese type 2 diabetic patients with hypertension: the COAT randomized controlled trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jul 2013

At a glance

  • Drugs Azelnidipine (Primary) ; Trichlormethiazide
  • Indications Glucose intolerance; Hypertension; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms COAT; COATS study
  • Most Recent Events

    • 22 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
    • 16 Apr 2013 Planned number of patients changed from 140 to 170 as reported by University Hospital Medical Information Network - Japan.
    • 31 Dec 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top